EXPERIMENTAL AUTOIMMUNE HEPATITIS - DISEASE INDUCTION, TIME COURSE AND T-CELL REACTIVITY

被引:119
作者
LOHSE, AW
MANNS, M
DIENES, HP
ZUMBUSCHENFELDE, KHM
COHEN, IR
机构
[1] UNIV MAINZ,MED KLIN & POLIKLIN 1,LANGENBECKSTR 1,W-6500 MAINZ,GERMANY
[2] WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL
[3] UNIV MAINZ,INST PATHOL,W-6500 MAINZ,GERMANY
关键词
D O I
10.1002/hep.1840110106
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This study describes a murine model of autoimmune hepatitis: experimental autoimmune hepatitis. Experimental autoimmune hepatitis could be induced most effectively in male C57BL/6 mice by intraperitoneal immunization with the 100,000 g superantant of syngeneic liver homogenate (S‐100) in complete Freund's adjuvant. BALB/C and C3H mice were less susceptible than C57BL/6 mice. Experimental autoimmune hepatitis could not be induced in Lewis rats. Intraperitoneal immunization was more effective than intramuscular or subcutaneous injections, and the amount of protein administered above a threshold was of little influence. A single intraperitoneal injection of S‐100 in complete Freund's adjuvant resulted in hepatitis of at least 6 mo duration. Histological changes were most marked 4 wk after disease induction. The histological findings were characterized mainly by perivascular inflammatory infiltrates and hepatocyte necroses. The histological changes were accompanied by biochemical evidence of liver cell death. Passive transfer of experimental autoimmune hepatitis with concanavalin. A–activated splenocytes was possible. Specific T‐cell reactivity against fractions of S‐100 could be demonstrated in vitro. Thus experimental autoimmune hepatitis is a murine model of autoimmune hepatitis probably mediated by autoreactive T cells. It will allow studies of the pathogenesis of autoimmune hepatitis. (HEPATOLOGY 1990; 11: 24–30.) Copyright © 1990 American Association for the Study of Liver Diseases
引用
收藏
页码:24 / 30
页数:7
相关论文
共 17 条
[1]  
ARAKI K, 1987, CLIN EXP IMMUNOL, V67, P326
[2]  
BRUSDEILINS M, 1983, J IMMUNOL, V131, P2427
[3]   REGULATION OF AUTOIMMUNE-DISEASE PHYSIOLOGICAL AND THERAPEUTIC [J].
COHEN, IR .
IMMUNOLOGICAL REVIEWS, 1986, 94 :5-21
[4]  
HOLOSHITZ J, 1986, LANCET, V2, P305
[5]  
KURIKI J, 1983, GASTROENTEROLOGY, V84, P596
[6]   CONTROL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY T-CELLS RESPONDING TO ACTIVATED T-CELLS [J].
LOHSE, AW ;
MOR, F ;
KARIN, N ;
COHEN, IR .
SCIENCE, 1989, 244 (4906) :820-822
[7]   SUBDIVISIONS OF IDIOPATHIC AUTOIMMUNE CHRONIC ACTIVE HEPATITIS [J].
MADDREY, WC .
HEPATOLOGY, 1987, 7 (06) :1372-1375
[8]   RELATIONSHIP BETWEEN THE TARGET ANTIGEN OF LIVER KIDNEY MICROSOMAL (LKM) AUTOANTIBODIES AND RAT ISOENZYMES OF CYTOCHROME-P-450 [J].
MANNS, M ;
KYRIATSOULIS, A ;
AMELIZAD, Z ;
GERKEN, G ;
LOHSE, A ;
RESKE, K ;
ZUMBUSCHENFELDE, KHM ;
OESCH, F .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1988, 2 (04) :245-248
[9]  
MANNS M, 1980, CLIN EXP IMMUNOL, V42, P263
[10]  
MANNS M, 1987, LANCET, V1, P292